Schott Pharma AG KGaA (MIL:1SXP) Common Stock: €150.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1SXP Schott Pharma AG & CO KGaA MIL:1SXP
65 GF Score
Price €20.15
GF Value €28.14
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA Common Stock?

Schott Pharma AG KGaA MIL:1SXP 65 Common Stock is €150.6 Mil as of Mar. 2026. GuruFocus rates MIL:1SXP with a GF Score™ of 65/100 and a GF Value™ of €28.14 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Schott Pharma AG KGaA's quarterly common stock stayed the same from Sep. 2025 (€150.6 Mil) to Dec. 2025 (€150.6 Mil) and stayed the same from Dec. 2025 (€150.6 Mil) to Mar. 2026 (€150.6 Mil).

Schott Pharma AG KGaA's annual common stock stayed the same from Sep. 2023 (€150.6 Mil) to Sep. 2024 (€150.6 Mil) and stayed the same from Sep. 2024 (€150.6 Mil) to Sep. 2025 (€150.6 Mil).

Schott Pharma AG KGaA Common Stock Historical Data

* Premium members only.

The historical data trend for Schott Pharma AG KGaA's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA Common Stock Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial 0.00 0.00 150.62 150.62 150.62

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.62 150.62 150.62 150.62 150.62
MIL:1SXP
65GF Score
Schott Pharma AG & CO KGaA MIL:1SXP
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Schott Pharma AG KGaA Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €150.6 Mil mean?
Schott Pharma AG KGaA (MIL:1SXP) has a Common Stock of €150.6 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Schott Pharma AG KGaA and its competitors.
Is Schott Pharma AG KGaA's Common Stock too high?
Schott Pharma AG KGaA's current Common Stock is €150.6 Mil. Overall, Schott Pharma AG KGaA has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Common Stock compare to ISRG and BDX?
Schott Pharma AG KGaA's Common Stock of €150.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Schott Pharma AG KGaA and its competitors. Schott Pharma AG KGaA's current Common Stock is €150.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Schott Pharma AG KGaA (MIL:1SXP) is currently considered Modestly Undervalued. The stock's GF Value™ is €28.14, compared to a current price of €20.15 — trading 28.4% below its estimated fair value. The current Common Stock is €150.6 Mil. Schott Pharma AG KGaA's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Schott Pharma AG KGaA (MIL:1SXP), the current Common Stock is €150.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Schott Pharma AG KGaA (MIL:1SXP) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €20.15 is trading 28.4% below its estimated GF Value™ of €28.14. GuruFocus considers Schott Pharma AG KGaA to be Modestly Undervalued.

Key valuation signals for MIL:1SXP:

  • Common Stock: €150.6 Mil
  • GF Value™: €28.14 vs. price of €20.15 (28.4% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the MIL:1SXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schott Pharma AG KGaA Business Description

Other Exchanges 1SXP:Germany1SXP:Austria
Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
65GF Score

Get the complete analysis for MIL:1SXP

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.15
Price
€28.14
GF Value